The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.50
Bid: 265.00
Ask: 280.00
Change: 2.00 (0.74%)
Spread: 15.00 (5.66%)
Open: 275.00
High: 275.00
Low: 272.00
Prev. Close: 270.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Update

28 Mar 2023 07:01

RNS Number : 3885U
Team17 Group PLC
28 March 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. 

 

28 March 2023

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Director Update

 

Team17 Group plc, a global games label, creative partner, developer, and publisher of independent ("indie") premium video games, educational entertainment apps for children and working simulation games, today announces that Debbie Bestwick MBE has indicated her intention to step down from her position as Chief Executive Officer of the Company once a suitable successor can be found.

 

A search for a suitable successor has been initiated and this will consider both external and internal candidates. Debbie will play a key part in finding the right person to replace her and will ensure that an orderly business handover takes place once that key person has been identified.

 

Debbie will remain with the business as Chief Executive Officer whilst the search for her successor is in progress. Her incredible passion and drive for Team17 remains undiminished and it is that passion and drive that will also be focussed on finding the right successor working closely with the board. Debbie will remain equally focussed on maintaining a "business-as-normal" mentality across the Group, with the senior team committed to delivering the Group's strategic ambitions.

 

Over the last eighteen months, a highly experienced and effective divisional senior leadership team has been established, that work closely together with the Executive team and are closely aligned to the Group's core values. This team now runs the day-to-day divisions within the Group and boasts extensive and unequalled gaming industry knowledge and operational experience.

 

Following a new CEO appointment, the intention is for Debbie to transition into a Non-Executive role, remaining on the Board to provide ongoing mentorship, support and guidance to the Board and the senior management team, ensuring the Group continues to benefit from her wealth of business and gaming sector experience.

 

Debbie Bestwick MBE, Chief Executive Officer of Team17, commented:

 

"This has probably been the hardest decision I've made, but I wouldn't have made it if I wasn't confident in the succession plans and the leadership team's ability to deliver the clear and focused strategy regarding our collective goals and ambitions. Ultimately, I want to spend more time with my children who have made sacrifices many times during my career and specifically to spend more time with my youngest before he goes to university.

 

"With Team17 now unrecognisable compared to those early days, and with our fantastic senior team working seamlessly across the business and our growth strategy firmly in place, now is the time to focus on the next generation.

 

"The future looks extremely bright for the Group, and I look forward to continuing to support the business to find my successor and then in a new capacity as a Non-Executive Director when that time arrives."

 

Chris Bell, Non-Executive Chair of Team17, commented:

 

"I would like to personally thank Debbie for her absolute devotion to Team17 and know that without her almost limitless enthusiasm for the business, we simply would not be where we are today. We all collectively wish her the very best in all her future endeavours and look forward to continuing to benefit from her unrivalled knowledge when she joins the Board as a Non-Executive Director.

 

"We the Board and Debbie are actively engaged in a search process to find a new Chief Executive Officer and will update our shareholders at the appropriate time. Knowing Debbie so well it will be "business-as-normal" and she will be 100%+ focused on her CEO duties right through".

 

 

Enquiries:

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Mark Crawford, Chief Financial Officer

 

via Vigo Consulting

 

Houlihan Lokey (Nominated Adviser)

Adrian Reed / Tim Richardson

 

+44 (0)161 250 3577

Berenberg (Broker)

Chris Bowman / Toby Flaux / Marie Moy / Alix Mecklenburg-Solodkoff

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Fiona Hetherington / Kate Kilgallen

team17@vigoconsulting.com 

 

+44 (0)20 7390 0233

 

About Team17

 

Team17 Group plc is a global provider of games entertainment to a broad audience. The Group now includes a games entertainment label and creative partner for indie developers, a leading developer of educational apps, targeting children under the age of eight and a leading working simulation games developer and publisher.

 

 Visit www.team17groupplc.com/  for more info.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBAORONUOUUR
Date   Source Headline
16th Apr 20247:00 amRNSUnaudited Final Results 2023
12th Apr 20241:16 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSNotice of Analyst & Investor Meetings, FY Results
19th Mar 20243:29 pmRNSHoldings in Company
13th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 20248:58 amRNSNotice of Results
14th Feb 20241:00 pmRNSDirector/PDMR Shareholding
13th Feb 20244:28 pmRNSDirector/PDMR Shareholding
1st Feb 20241:10 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
19th Jan 20243:01 pmRNSHolding(s) in Company
12th Jan 20244:53 pmRNSHolding(s) in Company
12th Jan 20243:04 pmRNSHolding(s) in Company
11th Jan 20243:23 pmRNSDirector/PDMR Shareholding
14th Dec 20239:15 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSDirector Dealings
27th Nov 20237:00 amRNSDirector Dealings
24th Nov 20237:00 amRNSTrading Update
15th Nov 20233:29 pmRNSHolding(s) in Company
13th Nov 20234:57 pmRNSDirector/PDMR Shareholding
30th Oct 20233:51 pmRNSHolding(s) in Company
18th Oct 202312:41 pmRNSHolding(s) in Company
11th Oct 20235:14 pmRNSDirector/PDMR Shareholding
21st Sep 20231:06 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.